Clorazepate Dipotassium Tablets Recalled for Tablet Discoloration Defects Nationwide
Aurobindo Pharma USA Inc. is recalling 6909 bottles of Clorazepate Dipotassium 7.5 mg tablets due to visible discoloration with yellow and dotted spots. No illnesses or injuries have been reported.
- Product
- CLORAZEPATE DIPOTASSIUM — CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)
- Category
- Drug
- Distribution
- Distributed nationwide